Byron P. Vaughn

Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study

Christopher Staley, Matthew J. Hamilton, Byron P. Vaughn et al. · The American Journal of Gastroenterology · 2017 · 245 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohnʼs Disease

Byron P. Vaughn, Tommi Vatanen, Jessica R. Allegretti et al. · Inflammatory Bowel Diseases · 2016 · 231 citations

Life Sciences, Immunology, Microbiology +17

Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab

Konstantinos Papamichael, Karen A. Chachu, Ravy K. Vajravelu et al. · Clinical Gastroenterology and Hepatology · 2017 · 221 citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +14

Proactive Therapeutic Concentration Monitoring of Infliximab May Improve Outcomes for Patients with Inflammatory Bowel Disease

Byron P. Vaughn, Manuel Martínez-Vazquez, Vilas Patwardhan et al. · Inflammatory Bowel Diseases · 2014 · 213 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection

Alexander Khoruts, Kevin Rank, Krista M. Newman et al. · Clinical Gastroenterology and Hepatology · 2016 · 213 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16